Amgen and Zhejiang Beta Pharma announce planned joint venture in China
Goal is to bring Amgen's Vectibix® (panitumumab) to chinese patients...
9 May 2013 | By Amgen
Goal is to bring Amgen's Vectibix® (panitumumab) to chinese patients...
List view / Grid view
Goal is to bring Amgen's Vectibix® (panitumumab) to chinese patients...
9 May 2013 | By Amgen
Goal is to bring Amgen's Vectibix® (panitumumab) to chinese patients...
Amgen outlined the company's long-term strategy during a Business Review…
7 February 2013 | By Amgen
Amgen outlined the company's long-term strategy during a Business Review meeting with analysts and investors in New York City...
Amgen appoints Anthony Hooper as Executive VP, Global Commercial Operations...
19 October 2011 | By Amgen
Amgen appoints Anthony Hooper as Executive VP, Global Commercial Operations...
Bristol-Myers Squibb Company announced a series of related changes within…
19 October 2011 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced a series of related changes within its Senior Management Team...
ORENCIA® (abatacept) treatment for adults with moderate to severe rheumatoid…
29 July 2011 | By Bristol-Myers Squibb
ORENCIA® (abatacept) treatment for adults with moderate to severe rheumatoid arthritis (RA)...